Recently, we demonstrated that chronic blockade of the renin-angiotensin system (RAS) lowered the blood pressure (BP) of adult Ren-2 transgenic rats (TGR) mainly through the attenuation of central sympathoexcitation. However, the participation of central and peripheral mechanisms in the development of high BP in immature TGR remains unclear. In the present study, 6-week-old heterozygous TGR males were chronically treated with intracerebroventricular (ICV) or intraperitoneal (IP) infusions of the AT1 receptor inhibitor losartan (1 or 2 mg/kg/day) for 4 weeks. The influence of these treatments on sympathetic- and angiotensin II-dependent BP components (BP response to pentolinium or captopril, respectively) as well as on BP response to exogenous angiotensin II were determined to evaluate the participation of central and peripheral RAS in hypertension development. Chronic IP losartan administration (1 or 2 mg/kg/day) lowered the BP of immature TGR by reducing both sympathetic and angiotensin II-dependent BP components. The central action of IP-administered losartan was indicated by a reduced BP response to acute ICV angiotensin II injection. Chronic ICV administration of a lower losartan dose (1 mg/kg/day) reduced only the sympathetic BP component, whereas a higher ICV administered dose (2 mg/kg/day) was required to influence the angiotensin II-dependent BP component. Accordingly, chronic ICV losartan administration of 2 mg/kg/day (but not 1 mg/kg/day) attenuated the BP response to acute intravenous angiotensin II application. In conclusion, central sympathoexcitation seems to play an important role in hypertension development in immature TGR. Central sympathoexcitation is highly susceptible to inhibition by low doses of RAS-blocking agents, whereas higher doses also affect peripheral angiotensin II-dependent vasoconstriction.

Institute of Physiology Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Lee MA, Böhm M, Paul M, Bader M, Ganten U, Ganten D. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol. 1996;270:E919–29. PubMed

Brosnan MJ, Devlin AM, Clark JS, Mullins JJ, Dominiczak AF. Different effects of antihypertensive agents on cardiac and vascular hypertrophy in the transgenic rat line TGR(mRen2)27. Am J Hypertens. 1999;12:724–31. PubMed

Rakušan D, Kujal P, Kramer HJ, Husková Z, Vaňourková Z, Vernerová Z, et al. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats. Am J Physiol Ren Physiol. 2010;299:F758–66.

Vaněčková I, Řezáčová L, Kuneš J, Zicha J. Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade. Life Sci. 2016;159:127–34. PubMed

Vaněčková I, Dobešová Z, Kuneš J, Zicha J. The effects of repeated delivery of angiotensin II A PubMed

Dampney RA, Polson JW, Potts PD, Hirooka Y, Horiuchi J. Functional organization of brain pathways subserving the baroreceptor reflex: studies in conscious animals using immediate early gene expression. Cell Mol Neurobiol. 2003;23:597–616. PubMed

Paton JF, Wang S, Polson JW, Kasparov S. Signalling across the blood brain barrier by angiotensin II: novel implications for neurogenic hypertension. J Mol Med. 2008;86:705–10. PubMed

Tsai CY, Poon YY, Chan JYH, Chan SHH. Baroreflex functionality in the eye of diffusion tensor imaging. J Physiol. 2019;597:41–55. PubMed

Dupont AG, Légat L. GABA is a mediator of brain AT PubMed

Ito S, Sved AF. Blockade of angiotensin receptors in rat rostral ventrolateral medulla removes excitatory vasomotor tone. Am J Physiol. 1996;270:R1317–23. PubMed

Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharm. 2003;139:191–202. https://doi.org/10.1038/sj.bjp.0705262 DOI

Muratani H, Averill DB, Ferrario CM. Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am J Physiol. 1991;260:R977–84. PubMed

Muratani H, Ferrario CM, Averill DB. Ventrolateral medulla in spontaneously hypertensive rats: role of angiotensin II. Am J Physiol. 1993;264:R388–95. PubMed

Tsai CY, Su CH, Baudrie V, Laude D, Weng JC, Chang AY, et al. Visualizing oxidative stress-induced depression of cardiac vagal baroreflex by MRI/DTI in a mouse neurogenic hypertension model. Neuroimage. 2013;82:190–9. PubMed

Su CH, Tsai CY, Chang AY, Chan JY, Chan SH. MRI/DTI of the brain stem reveals reversible and irreversible disruption of the baroreflex neural circuits: clinical implications. Theranostics. 2016;6:837–48. PubMed PMC

Lebrun CJ, Blume A, Herdegen T, Möllenhoff E, Unger T. Complex activation of inducible transcription factors in the brain of normotensive and spontaneously hypertensive rats following central angiotensin II administration. Regul Pept. 1996;66:19–23. PubMed

Chan JY, Chen WC, Lee HY, Chan SH. Elevated Fos expression in the nucleus tractus solitarii is associated with reduced baroreflex response in spontaneously hypertensive rats. Hypertension. 1998;32:939–44. PubMed

Chan JY, Wang LL, Lee HY, Chan SH. Augmented upregulation by c-fos of angiotensin subtype 1 receptor in nucleus tractus solitarii of spontaneously hypertensive rats. Hypertension. 2002;40:335–41. PubMed

Diz DI, Garcia-Espinosa MA, Gallagher PE, Ganten D, Ferrario CM, Averill DB. Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats. J Cardiovasc Pharmacol. 2008;51:542–8. PubMed PMC

Isa K, Arnold AC, Westwood BM, Chappell MC, Diz DI. Angiotensin-converting enzyme inhibition, but not AT PubMed PMC

Nautiyal M, Shaltout HA, de Lima DC, do Nascimento K, Chappell MC, Diz DI. Central angiotensin-(1-7) improves vagal function independent of blood pressure in hypertensive (mRen2)27 rats. Hypertension. 2012;60:1257–65. PubMed

Řezáčová L, Hojná S, Kopkan L, Rauchová H, Kadlecová M, Zicha J, et al. Role of angiotensin II in chronic blood pressure control of heterozygous Ren-2 transgenic rats: peripheral vasoconstriction versus central sympathoexcitation. Biomed Pharmacother. 2019;116:108996. PubMed

Berecek KH, Okuno T, Nagahama S, Oparil S. Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat. Hypertension. 1983;5:689–700. PubMed

Berecek KH, Kirk KA, Nagahama S, Oparil S. Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril. Am J Physiol. 1987;252:H796–806. PubMed

Wilson KM, Magargal W, Berecek KH. Long-term captopril treatment. Angiotensin II receptors and responses. Hypertension. 1988;11(Suppl I):I148–52. PubMed

Nishimura Y, Xu T, Jöhren O, Häuser W, Saavedra JM. The angiotensin AT PubMed

Leenen FH, Yuan B. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade. Hypertension. 2001;37:981–4. PubMed

Zicha J, Kuneš J. Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Rev. 1999;79:1227–82. PubMed

Dahl LK, Knudsen KD, Heine MA, Leitl GJ. Effects of chronic excess salt ingestion. Modification of experimental hypertension in the rat by variations in the diet. Circ Res. 1968;22:11–8. PubMed

Zicha J, Byšková E, Kuneš J, Pohlová I, Jelínek J. Sodium pump activity in young and adult salt hypertensive Dahl rats. Klin Wochenschr. 1987;65(Suppl 8):76–81. PubMed

Dobešová Z, Kuneš J, Zicha J. The altered balance between sympathetic nervous system and nitric oxide in salt hypertensive Dahl rats: ontogenetic and F2 hybrid studies. J Hypertens. 2002;20:945–55. PubMed

Heijnen BF, Peutz-Kootstra CJ, Mullins JJ, Janssen BJ, Struijker-Boudier HA. Transient renin-angiotensin system stimulation in an early stage of life causes sustained hypertension in rats. J Hypertens. 2011;29:2369–80. PubMed

Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension. 1990;16:603–14. PubMed

Zicha J, Dobešová Z, Behuliak M, Pintérová M, Kuneš J, Vaněčková I. Nifedipine-sensitive blood pressure component in hypertensive models characterized by high activity of either sympathetic nervous system or renin-angiotensin system. Physiol Res. 2014;63:13–26. PubMed

Averill DB, Matsumura K, Ganten D, Ferrario CM. Role of area postrema in transgene hypertension. Hypertension. 1996;27:591–7. PubMed

Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Burlington, MA: Elsevier Academic Press; 2005.

Minami N, Imai Y, Hashimoto J, Abe K. Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive Wistar Kyoto rats. Clin Sci. 1995;89:177–82.

Zicha J, Dobešová Z, Kuneš J. Late blood pressure reduction in SHR subjected to transient captopril treatment in youth: possible mechanisms. Physiol Res. 2008;57:495–8. PubMed

Behuliak M, Bencze M, Polgárová K, Kuneš J, Vaněčková I, Zicha J. Hemodynamic response to gabapentin in conscious spontaneously hypertensive rats. Hypertension. 2018;72:676–85. PubMed

Vavřínová A, Behuliak M, Bencze M, Vodička M, Ergang P, Vaněčková I, et al. Sympathectomy-induced blood pressure reduction in adult normotensive and hypertensive rats is counteracted by enhanced cardiovascular sensitivity to vasoconstrictors. Hypertens Res. 2019;42:1872–82. PubMed

Seltzer A, Bregonzio C, Armando I, Baiardi G, Saavedra JM. Oral administration of an AT PubMed

Kawano Y, Yoshida K, Matsuoka H, Omae T. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats. Am J Hypertens. 1994;7:536–42. PubMed

Okuno T, Nagahama S, Lindheimer MD, Oparil S. Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril. Hypertension. 1983;5:653–62. PubMed

Aileru AA, Logan E, Callahan M, Ferrario CM, Ganten D, Diz DI. Alterations in sympathetic ganglionic transmission in response to angiotensin II in (mRen2)27 transgenic rats. Hypertension. 2004;43:270–5. PubMed

Thybo NK, Korsgaard N, Mulvany MJ. Morphology and function of mesenteric resistance arteries in transgenic rats with low-renin hypertension. J Hypertens. 1992;10:1191–6. PubMed

Struijker-Boudier HA, van Essen H, Fazzi G, De Mey JG, Qiu HY, Lévy BI. Disproportional arterial hypertrophy in hypertensive mRen-2 transgenic rats. Hypertension. 1996;28:779–84. PubMed

Teisman AC, Pinto YM, Buikema H, Flesch M, Böhm M, Paul M, et al. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats. J Hypertens. 1998;16:1759–65. PubMed

Rossi GP, Cavallin M, Belloni AS, Mazzocchi G, Nussdorfer GG, Pessina AC, et al. Aortic smooth muscle cell phenotypic modulation and fibrillar collagen deposition in angiotensin II-dependent hypertension. Cardiovasc Res. 2002;55:178–89. PubMed

Ding J, Yu M, Jiang J, Luo Y, Zhang Q, Wang S, et al. Angiotensin II decreases endothelial nitric oxide synthase phosphorylation via AT PubMed PMC

Arnet UA, Novosel D, Barton M, Noll G, Ganten D, Lüscher TF. Endothelial dysfunction in the aorta of transgenic rats harboring the mouse Ren-2 gene. Endothelium. 1999;6:175–84. PubMed

Dampney RA, Li YW, Hirooka Y, Potts P, Polson JW. Use of c-fos functional mapping to identify the central baroreceptor reflex pathway: advantages and limitations. Clin Exp Hypertens. 1995;17:197–208. PubMed

Lohmeier TE, Lohmeier JR, Warren S, May PJ, Cunningham JT. Sustained activation of the central baroreceptor pathway in angiotensin hypertension. Hypertension. 2002;39:550–6. PubMed

Altered Balance between Vasoconstrictor and Vasodilator Systems in Experimental Hypertension

Blood pressure reduction induced by chronic intracerebroventricular or peroral clonidine administration in rats with salt-dependent or angiotensin II-dependent hypertension